CRISPR Therapeutics AG (CRSP) — Dilution Risk Analysis
Current Snapshot
CRISPR Therapeutics AG (CRSP) has a DilutionWatch score of 15/10 and is classified as LOW risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 15/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: 4 9, 8-K 1.
| Form | Filed | Accession |
|---|---|---|
| 4 | 2026-03-24 | 0001193125-26-122267 |
| 4 | 2026-03-24 | 0001193125-26-122268 |
| 4 | 2026-03-24 | 0001193125-26-122272 |
| 4 | 2026-03-24 | 0001193125-26-122274 |
| 4 | 2026-03-17 | 0001193125-26-111278 |
| 4 | 2026-03-17 | 0001193125-26-111281 |
| 4 | 2026-03-17 | 0001193125-26-111284 |
| 4 | 2026-03-17 | 0001193125-26-111286 |
| 8-K | 2026-03-16 | 0001193125-26-108333 |
| 4 | 2026-03-12 | 0001193125-26-104480 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 640 months | Source |
| Three-year share count growth | 21.73% | Source |
DilutionWatch Analysis
- Risk Level
- LOW (Score: 15/10) Source
- Cash Runway
- 640 months Source
- Share Count Growth (3-Year)
- 21.73% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.